AVfloTM VASCULAR ACCESS GRAFT Izrael - hebrejski - Ministry of Health

avflotm vascular access graft

nicast ltd. - מומחה - the avflotm vascular access graft’s proposed indication for use is as a subcutaneous, arteriovenous conduit for blood access

MGuard Prime Izrael - hebrejski - Ministry of Health

mguard prime

inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).

דקסטרוז % 5 ו - % 0.9 סודיום כלוריד הנתרן להזרקה Izrael - hebrejski - Ministry of Health

דקסטרוז % 5 ו - % 0.9 סודיום כלוריד הנתרן להזרקה

teva medical ltd - glucose as monohydrate; sodium chloride - תמיסה לאינפוזיה - glucose as monohydrate 5 %; sodium chloride 0.9 % - combinations - combinations - intravenous solutions are indicated as a source of water, electrolytes and/or calories.

דקסאקורט פורטה Izrael - hebrejski - Ministry of Health

דקסאקורט פורטה

teva pharmaceutical indust.ltd - dexamethasone sodium phosphate 20 mg/ml - solution for injection - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.

דקסאקורט פורטה Izrael - hebrejski - Ministry of Health

דקסאקורט פורטה

teva pharmaceutical industries ltd, israel - dexamethasone sodium phosphate - תמיסה להזרקה - dexamethasone sodium phosphate 20 mg/ml - dexamethasone - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.

ונופר Izrael - hebrejski - Ministry of Health

ונופר

cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.

ונופר Izrael - hebrejski - Ministry of Health

ונופר

cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.

אמיודקור זריקות Izrael - hebrejski - Ministry of Health

אמיודקור זריקות

sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP Izrael - hebrejski - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP Izrael - hebrejski - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.